TWI324935B - - Google Patents

Download PDF

Info

Publication number
TWI324935B
TWI324935B TW91118344A TW91118344A TWI324935B TW I324935 B TWI324935 B TW I324935B TW 91118344 A TW91118344 A TW 91118344A TW 91118344 A TW91118344 A TW 91118344A TW I324935 B TWI324935 B TW I324935B
Authority
TW
Taiwan
Prior art keywords
sleep
melatonin
agent
quality
agents
Prior art date
Application number
TW91118344A
Other languages
English (en)
Chinese (zh)
Inventor
Zisapel Nava
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Priority to TW91118344A priority Critical patent/TWI324935B/zh
Application granted granted Critical
Publication of TWI324935B publication Critical patent/TWI324935B/zh

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW91118344A 2002-08-09 2002-08-09 TWI324935B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW91118344A TWI324935B (de) 2002-08-09 2002-08-09

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW91118344A TWI324935B (de) 2002-08-09 2002-08-09

Publications (1)

Publication Number Publication Date
TWI324935B true TWI324935B (de) 2010-05-21

Family

ID=45074208

Family Applications (1)

Application Number Title Priority Date Filing Date
TW91118344A TWI324935B (de) 2002-08-09 2002-08-09

Country Status (1)

Country Link
TW (1) TWI324935B (de)

Similar Documents

Publication Publication Date Title
US20100249164A1 (en) Modulation of sleep with nr2b receptor antagonists
MXPA02001568A (es) Ciclobenzaprina para tratar trastornos de ansiedad generalizada y composiciones de la misma.
KR20140136982A (ko) 치료-불응성 또는 치료-저항성 우울증 치료용 에스케타민
EP1202722A1 (de) Verwendungen und zusammensetungen zur behandlung oder vermeidung von schlafstörungen mit sehr niedrigdosierten cyclobenzaprine
DK1441702T3 (en) Method of treating primary insomnia
CA2333666A1 (en) Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
EP1553946A2 (de) Verbesserung des schlafs mit kalziumkanal-antagonisten vom t-typ
EP0759299A1 (de) Potenzierung von Serotonin-Wirkstoffresponz
US20210177830A1 (en) Compositions for treating or preventing vasomotor symptoms
TWI324935B (de)
US20090281112A1 (en) Adatanserin and metabolites thereof for treatment of attention deficit disorder, anxiety, depression, sexual dysfunction, and other disorders
US20020142942A1 (en) Method for treating premenstrual or late luteal phase syndrome
TW201929855A (zh) 用於治療或預防血管舒縮症狀的組成物及方法
TW200824677A (en) Method of treatment or prophylaxis of depression
WO2010136964A1 (en) Method of treating sleep disorders using the combination of eplivanserin and zolpidem

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent